About ASH
Scientific Meetings
HTN Community Outreach
ASH Foundation Overview
Corporate Members
Related Organizations
Position Papers
ASH Home About Hypertension For Proffesionals For Patients HTN Specialist Membership
American Society of Hypertension (ASH) Members Log in
Make text larger
Home » Scientific Meetings » Scientific Awards » ASH Marvin Moser Clinical HTN Award

ASH Marvin Moser Clinical Hypertension Award

ASH announced a new award in 2009, the Marvin Moser Clinical Hypertension Award. The Society will recognize a qualified Hypedrtension Clinician for his or her dedication to the treatment and care of hypertensive patients. The award will be given at the ASH Annual Scientific Meeting. The award recipient will receive a $5,000 honorarium, given by the Hypertension Education Foundation, as well as complimentary registration to the ASH Annual Scientific Meeting and reimbursement for travel expenses and hotel accommodations for two nights to attend the Annual Meeting. In addition, the award recipient will be recognized at the ASH Annual Scientific Meeting during the Awards Plenary Session.



Must have been involved in treating hypertensive patients as a major component of his or her practice experience
Must be currently active in teaching
May have had an active role in developing guidelines and in clinical trials that focus on improving blood pressure control
May be involved in community programs

Application Requirements

Only ASH Members can nominate candidates
Sponsor submission of complete name, address, phone/fax numbers, and e-mail address of nominee
Signed letter of nomination articulating major contributions of nominee to the treatment and care of hypertensive patients
At least one additional supporting letter
Complete curriculum vitae

Please send all nomination materials to:

Ashley Buron
Program Coordinator
American Society of Hypertension, Inc.
45 Main Street, suite #712
Brooklyn, NY 11201
Phone: 212.696.9099
Fax: 347.916.0267

The American Society of Hypertension is pleased to announce the recipient of the ASH Marvin Moser Clinical Hypertension Award. This award recognizes a qualified Hypertension Clinician for his or her dedication to the treatment and care of hypertensive patients.

The 2013 Award was presented during the ASH Twenty-Eigth Annual Scientific Meeting during the Awards Plenary Session on Friday, May 17, 2013.

2013 Award Recipient

C .Venkata S. Ram, MD, MACP, FACC, FASH
President and Chief Executive Officer
MediCiti Institute of Medical Sciences
MediCiti Hospitals
MediCiti Medical College
Hyderabad and Medchal, A.P, India

An experienced clinical scholar in the field of hypertension with a broad range of scientific contributions to the field is this year’s Marvin Moser Clinical Hypertension Award recipient. Dr. C. Venkata S. Ram serves as the President and Chief Executive Officer of MediCiti Medical College, MediCiti Hospital, and MediCiti Institute of Medical Sciences, Medchal and Hyderabad, A.P, India. A founding member of American Society of Hypertension, Dr. Ram has served the Society in many capacities including as a member of the Executive Council, Board of Governors, and as Vice-President. He has made significant contributions to the growth of ASH. He now serves as the ASH liaison for international programs and as the Vice-President of the ASH Specialists Program. Dr. Ram serves on the editorial boards of The Journal of Clinical Hypertension, the Journal of the American Society of Hypertension, American Journal of Cardiology, American Journal of Therapeutics, American Journal of Cardiovascular Drugs, Journal of Clinical and Preventive Cardiology, and the Journal of Preventive Cardiology and has served as a reviewer consultant to various Joint National Committee (JNC) reports. Dr. Ram graduated from Osmania Medical College, Hyderabad, India, and trained as a resident at Brown University. After a fellowship at the University of Pennsylvania, he was recruited by Drs. Norman Kaplan and Donald Seldin to join the University of Texas Southwestern Medical School in 1977. He was instrumental in developing clinical services and research activities in hypertension at the Parkland Memorial Hospital and University of Texas Southwestern Medical School in Dallas where he also started a fellowship program in hypertension along with Dr. Kaplan. Students, residents, fellows and staff recognized Dr. Ram as an outstanding clinician and role model during his time as president of the St. Paul University Hospital, Dallas, medical staff, chairman of the Institutional Review Board at St. Paul and president of the American Association of Physicians from India (AAPI). He received the best teacher "Aesculapius” award from the St. Paul house staff. As the director of the hypertension clinics in Dallas, Dr. Ram provided leadership in the care and follow-up of patients with complex and secondary forms of hypertension and established a popular referral clinic on the campus. Dr. Ram was selected as the American Heart Association international visiting scholar and received a “Mother India” award from the Non-Resident Indian (NRI) Institute, New Delhi, for his contributions to preventive medicine and global cardiovascular health. He was recently conferred the prestigious “PADMA SHRI” award by the government of India in 2013 for his “impactful” and “significant” contributions in the field of medicine; PADMA SHRI is one of the highest civilian recognitions in India. Dr. Ram has authored 308 publications, including book chapters and booklets, and co-edited the book “Individualised Therapy of Hypertension.” He just completed another book, “Hypertension: A Clinical Guide.”

Dr. Ram’s research covered various physiological, pathophysiological, diagnostic, and therapeutic dimensions of hypertension. As a resident he pointed out the potential risk of diabetes in patients exposed to diuretics and was one of the first researchers to show an additive interaction between the loop diuretics and metolazone. His early work touched on fundamental aspects of hypertension with significant clinical implications, and he has recently shown the value of combination therapy to achieve goal blood pressure levels in patients with diabetes and clinical outcomes in patients treated with ARBs. Focusing on community health economics, he has analyzed the comparative effectiveness of fixed combinations in hypertension. Dr. Ram and co-workers published extensively on the therapeutic efficacy of various antihypertensive drugs introduced in the last three decades. His continued contributions to the science of hypertension include subclinical cardiovascular disease in metabolic syndrome, cytokine activation in heart failure, ACE gene polymorphism in South Asians, resistant hypertension, mechanical devices to treat hypertension, clinical outcomes in patients with hypertension, central aortic blood pressure and combination therapy.